Endothelial Cpt1a Inhibits Neonatal Hyperoxia‐Induced Pulmonary Vascular Remodeling by Repressing Endothelial‐Mesenchymal Transition
Advanced Science · 2025
DOI: 10.1002/advs.202415824 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advanced Science, 2025. Verfasst von Xiaoyun Li und 14 weiteren Autor:innen. Beteiligte Einrichtung: Department of Molecular Biology, Cellular Biology, and Biochemistry, Brown University, Providence, RI, 02912, USA. Hauptthemen laut MEDLINE: Vascular Remodeling, Hyperoxia, Carnitine O-Palmitoyltransferase, Endothelial Cells. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 73 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NHLBI NIH HHS, Rhode Island Foundation, Warren Alpert Foundation of Brown University (PAD).
Abstract (Originalsprache)
Pulmonary hypertension (PH) increases the mortality of preterm infants with bronchopulmonary dysplasia (BPD). There are no curative therapies for this disease. Lung endothelial carnitine palmitoyltransferase 1a (Cpt1a), the rate‐limiting enzyme of the carnitine shuttle system, is reduced in a rodent model of BPD. It is unknown whether endothelial Cpt1a reduction causes pulmonary vascular (PV) remodeling. The latter can be the result of endothelial‐mesenchymal transition (EndoMT). Here, endothelial cell (EC)‐specific Cpt1a KO and WT mice (
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Molecular Biology, Cellular Biology, and Biochemistry, Brown University, Providence, RI, 02912, USA.
- Providence VA Medical Center, Providence, RI, 02908, USA.
- Division of Cardiology, Department of Medicine, Warren Alpert Medical School of Brown University, Providence, RI, 02903, USA.
- College of Pharmacy, Jinan University, Guangzhou, Guangdong, 510632, China.
- State Key Laboratory of Respiratory Disease, Guangdong Key Laboratory of Vascular Disease, National Clinical Research Center for Respiratory Disease, Guangzhou Institute of Respiratory Health, The First Affiliated Hospi…
- College of Arts & Sciences, Boston University, Boston, MA, 02215, USA.
ORCID-Profile: Hongwei Yao
Förderung
- NHLBI NIH HHS
- Rhode Island Foundation
- Warren Alpert Foundation of Brown University (PAD)
- NIGMS NIH HHS
- Institutional Development Award (IDeA) from the NIGMS of NIH
- National Institute of Health (NIH)
Zitieren
APA
Li, X., Hegarty, K., Lin, F., Chang, J. L., Abdalla, A., Dhanabalan, K., Solomevich, S. O., Song, W., Roder, K., Yao, C., Lu, W., Carmeliet, P., Choudhary, G., Dennery, P. A., & Yao, H. (2025). Endothelial Cpt1a Inhibits Neonatal Hyperoxia‐Induced Pulmonary Vascular Remodeling by Repressing Endothelial‐Mesenchymal Transition. Advanced Science. https://doi.org/10.1002/advs.202415824
Vancouver
Li X, Hegarty K, Lin F, Chang JL, Abdalla A, Dhanabalan K, et al. Endothelial Cpt1a Inhibits Neonatal Hyperoxia‐Induced Pulmonary Vascular Remodeling by Repressing Endothelial‐Mesenchymal Transition. Advanced Science. 2025. doi:10.1002/advs.202415824
BibTeX
@article{Li2025,
author = {Li, Xiaoyun and Hegarty, Katy and Lin, Fanjie and Chang, Jason L and Abdalla, Amro and Dhanabalan, Karthik and Solomevich, Sergey O and Song, Wenliang and Roder, Karim and Yao, Chenrui and Lu, Wenju and Carmeliet, Peter and Choudhary, Gaurav and Dennery, Phyllis A and Yao, Hongwei},
title = {Endothelial Cpt1a Inhibits Neonatal Hyperoxia‐Induced Pulmonary Vascular Remodeling by Repressing Endothelial‐Mesenchymal Transition},
journal = {Advanced Science},
year = {2025},
doi = {10.1002/advs.202415824}
}
EUVIMED